Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
14.04
-0.25 (-1.75%)
Nov 20, 2024, 4:00 PM EST - Market closed
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $203.24 million as of November 21, 2024.
Market Cap
203.24M
Enterprise Value
8.74M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.04
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $203.24M, an increase of 2.52%. That is a compound annual growth rate of 5.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 206.86M | 4.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 203.32M |
| Enanta Pharmaceuticals | 202.77M |
| Jin Medical International | 201.95M |
| Solid Biosciences | 199.77M |
| Lexeo Therapeutics | 198.40M |
| Acrivon Therapeutics | 195.22M |
| Profound Medical | 194.34M |
| Amarin Corporation | 191.27M |